Changes in triglyceride levels over time and risk of type 2 diabetes in young men

Diabetes Care

Volumn 31, Issue 10, 2008, Pages 2032-2037

  Tirosh, Amir ^a   Shai, Iris ^b   Bitzur, Rafael ^a   Kochba, Ilan ^c   Tekes Manova, Dorit ^c   Israeli, Eran ^c   Shochat, Tzippora ^c   Rudich, Assaf ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c MEDICAL CORPS   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; EATING HABIT; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PHYSICAL ACTIVITY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION;

ADULT; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PREDIABETIC STATE; TRIGLYCERIDES;

EID: 56149103696     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0825     Document Type: Article

References (23)

1. Ginsberg HN, Zhang YL, Hernandez-Ono A: Regulation of plasma triglycerides in insulin resistance and diabetes. Arch MedRes 36:232-240, 2005
2. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
3. Alberti KG, Zimmet P, ShawJ: IDF Epidemiology Task Force Consensus Group: the metabolic syndrome-a new worldwide definition. Lancet 366:1059-1062. 2005
4. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 48:1684-1699, 2005
5. Dotevall A, Johansson S, Wilhelmsen L, Rosengren A: Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women: a prospective 18-year follow-up of the BEDA study. Díabet Med 21:615-622, 2004
6. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG: Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 310: 560-564, 1995
7. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE: Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 28:2013-2018, 2005
8. McPhillips JB, Barrett-Connor E, Wingard DL: Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am ] Epidemiol 131:443-453, 1990
9. Mykkanen L, Kuusisto J, Pyorala K, Laakso M: Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36:553-559, 1993
10. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A: Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353:1454-1462, 2005
11. Ginsberg HN: Nonpharmacologic management of low levels of high-density li-poprotein cholesterol. Am J Cardiol 86:41-45L, 2000
12. Szapary PO, Bloedon LT, Foster GD: Physical activity and its effects on lipids. Curr Cardiol Rep 5:488-492, 2003
13. Tirosh A, Rudich A, Shochat T, Tekes-Manova D, Israeli E, Henkin Y, Kochba I,Shai I: Changes in triglyceride levels and risk for coronary heart disease in young men. Ann Intern Med 147:377-385, 2007
14. Bloomgarden ZT: Type 2 diabetes in the young: the evolving epidemic. Diabetes Care 27:998-1010, 2004
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
16. Juonala M, Viikari JS, Hutri-Kahonen N, Pietikainen M, Jokinen E, Taittonen L, Marniemi J, Ronnemaa T, Raitakari OT: The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. J Intern Med 255:457-468, 2004
17. Urbina EM, Srinivasan SR, Kieltyka RL, Tang R, Bond MG, ChenW, Berenson GS: Correlates of carotid artery stiffness in young adults: the Bogalusa Heart Study. Atherosclerosis 176:157-164, 2004
18. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
19. McLaughlin T, Reaven G, Abbasi F, La-mendola C, Saad M, Waters D, Simon J, Krauss RM: Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am] Cardiol 96:399-404, 2005
20. Boden G, Shulman GI: Free fatty acids in obesity and type 2 diabetes: defining the role in the development of insulin resistance and ß-cell dysfunction. Eur J Clin Invest 32 (Suppl. 3): 14-23, 2002
21. Enger SC, Johnsen V, Samuelsen A, Laws EA: The effect of do fib rate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease. Ada Med Scand 201:563-566, 1977
22. Panz VR, Wing JR, Raal FJ, Kedda MA, Joffe BI: Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Ran-dle's cycle in its pathogenesis? Clín Endo-crínol (Oxf) 46:365-368, 1997
23. Santomauro AT, Boden G, Suva ME, Rocha DM, Santos RF, Ursich MJ, Strass-mann PG, Wajchenberg BL: Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese, diabetic and non-diabetic subjects. Diabetes 48:1836-1841, 1999